Ghrelin restores 'lean-type' hunger and energy expenditure profiles in morbidly obese subjects but has no effect on postgastrectomy subjects

International Journal of Obesity

Volumn 33, Issue 3, 2009, Pages 317-325

  Huda, M S B ^a,c   Dovey, T ^a   Wong, S P ^a   English, P J ^a   Halford, J ^a   McCulloch, P ^b   Cleator, J ^a   Martin, B ^a   Cashen, J ^a   Hayden, K ^b   Wilding, J P H ^a   Pinkney, J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Gastrectomy; Ghrelin; Hunger

Indexed keywords

GHRELIN; PLACEBO; SODIUM CHLORIDE; APPETITE STIMULANT; GLUCOSE BLOOD LEVEL;

ADULT; APPETITE; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CALORIC INTAKE; CALORIMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; GASTRECTOMY; HUMAN; HUNGER; LEAN BODY WEIGHT; MALE; MEAL; METABOLIC RATE; MORBID OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY QUOTIENT; SCORING SYSTEM; VISUAL ANALOG SCALE; DRUG EFFECTS; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTPRANDIAL STATE; PSYCHOPHYSIOLOGY;

ADULT; APPETITE; APPETITE STIMULANTS; BLOOD GLUCOSE; DOUBLE-BLIND METHOD; ENERGY METABOLISM; FEMALE; GASTRECTOMY; GHRELIN; HUMANS; HUNGER; MALE; MIDDLE AGED; OBESITY, MORBID; PAIN MEASUREMENT; POSTPRANDIAL PERIOD; SATIETY RESPONSE;

EID: 62349089170     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2008.270     Document Type: Article

References (35)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
2. Druce MR, Wren AM, Park AJ, Milton JE, Patterson M, Frost G et al. Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) 2005; 29: 1130-1136.
3. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992.
4. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001; 50: 2540-2547.
5. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-1719.
6. Cummings DE, Frayo RS, Marmonier C, Aubert R, Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab 2004; 287: E297-E304.
7. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913.
8. English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JP. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 2002; 87: 2984.
9. De JL, Bray GA. The thermic effect of food and obesity: a critical review. Obes Res 1997; 5: 622-631.
10. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-4261.
11. Dornonville de la CC, Bjorkqvist M, Sandvik AK, Bakke I, Zhao CM, Chen D et al. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept 2001; 99: 141-150.
12. Le Roux CW, Neary NM, Halsey TJ, Small CJ, Martinez-Isla AM, Ghatei MA et al. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 2005; 90: 4521-4524.
13. Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004; 89: 2832-2836.
14. Karlsson J, Persson LO, Sjostrom L, Sullivan M. Psychometric properties and factor structure of the Three-Factor Eating Questionnaire (TFEQ) in obese men and women. Results from the Swedish Obese Subjects (SOS) study. Int J Obes Relat Metab Disord 2000; 24: 1715-1725.
15. Barkeling B, King NA, Naslund E, Blundell JE. Characterization of obese individuals who claim to detect no relationship between their eating pattern and sensations of hunger or fullness. Int J Obes (Lond) 2007; 31: 435-439.
16. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-709.
17. le Roux CW, Batterham RL, Aylwin SJ, Patterson M, Borg CM, Wynne KJ et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006; 147: 3-8.
18. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003; 349: 941-948.
19. Verdich C, Toubro S, Buemann B, Lysgard MJ, Juul HJ, Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int J Obes Relat Metab Disord 2001; 25: 1206-1214.
20. Jeon TY, Lee S, Kim HH, Kim YJ, Son HC, Kim DH et al. Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab 2004; 89: 5392-5396.
21. Pekic S, Pesko P, Djurovic M, Miljic D, Doknic M, Glodic J et al. Plasma ghrelin levels of gastrectomized and vagotomized patients are not affected by glucose administration. Clin Endocrinol (Oxf) 2006; 64: 684-688.
22. Damjanovic SS, Lalic NM, Pesko PM, Petakov MS, Jotic A, Miljic D et al. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients. J Clin Endocrinol Metab 2006; 91: 2574-2581.
23. Popovic V, Miljic D, Pekic S, Pesko P, Djurovic M, Doknic M et al. Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release. J Clin Endocrinol Metab 2005; 90: 2187-2191.
24. Buhl K, Schlag P, Herfarth C. Quality of life and functional results following different types of resection for gastric carcinoma. Eur J Surg Oncol 1990; 16: 404-409.
25. Bozzetti F, Ravera E, Cozzaglio L, Dossena G, Agradi E, Bonfanti G et al. Comparison of nutritional status after total or subtotal gastrectomy. Nutrition 1990; 6: 371-375.
26. Takachi K, Doki Y, Ishikawa O, Miyashiro I, Sasaki Y, Ohigashi H et al. Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. J Surg Res 2006; 130: 1-7.
27. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H et al. The role of the gastric afferent vagal nerve in ghrelininduced feeding and growth hormone secretion in rats. Gastroenterology 2002; 123: 1120-1128.
28. Arnold M, Mura A, Langhans W, Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci 2006; 26: 11052-11060.
29. Bergh C, Sjostedt S, Hellers G, Zandian M, Sodersten P. Meal size, satiety and cholecystokinin in gastrectomized humans. Physiol Behav 2003; 78: 143-147.
30. Olsson U, Bergbom I, Bosaeus I. Patients' experiences of their intake of food and fluid following gastrectomy due to tumor. Gastroenterol Nurs 2002; 25: 146-153.
31. Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 2004; 101: 8227-8232.
32. Labayen I, Diez N, Parra D, Gonzalez A, Martinez JA. Basal and postprandial substrate oxidation rates in obese women receiving two test meals with different protein content. Clin Nutr 2004; 23: 571-578.
33. Longo KA, Charoenthongtrakul S, Giuliana DJ, Govek EK, McDonagh T, Qi Y et al. Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice. Regul Pept 2008; 150: 55-61.
34. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 2004; 89: 3062-3065.
35. Neary NM, Druce MR, Small CJ, Bloom SR. Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut 2006; 55: 135.